Contact
searchSearch
HMP Global

Hidradenitis Suppurativa Topic Center

Featured

Face
FDA Alerts
Bimekizumab FDA Approved for Moderate to Severe Hidradenitis Suppurativa
11/20/2024
Riya Gandhi, MA
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug...
11/20/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
FDA Alerts
Secukinumab Approved as New Biologic Treatment Option for Hidradenitis Suppurativa
11/01/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist
News
Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa
07/18/2023
Jessica Garlewicz
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a...
07/18/2023
The Dermatologist
News
Smoking and Obesity Are Important Research Questions for Managing Hidradenitis Suppurativa
04/10/2023
Lisa Kuhns, PhD, MD
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority...
04/10/2023
The Dermatologist
News
Complete Remission of Hidradenitis Suppurativa Reported After Treatment With Thoracodorsal Artery Perforator Flap
04/05/2023
Lisa Kuhns, PhD, MD
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator...
04/05/2023
The Dermatologist
News
Effectiveness and Pain Reduction Identified as the Most Important Treatment Attributes in Hidradenitis Suppurativa Management
01/31/2023
Lisa Kuhns, PhD, MD
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete...
01/31/2023
The Dermatologist
News
Hidradenitis Suppurativa Contributes to Relationship Disturbances
12/08/2022
Lisa Kuhns, PhD, MD
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine...
12/08/2022
The Dermatologist
News
Pediatric Hidradenitis Suppurativa Presents Similar Clinical Spectrum to Adult-Onset Disease
11/30/2022
Lisa Kuhns, PhD, MD
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
Stigmatization Has a Debilitating Impact on Patients With Hidradenitis Suppurativa
11/18/2022
Lisa Kuhns, PhD, MD
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an...
11/18/2022
The Dermatologist
News
Increased Epigenetic Age May Be a Biomarker of Disease Burden in Hidradenitis Suppurativa
11/09/2022
Lisa Kuhns, PhD, MD
Researchers performed a pilot study to calculate EAA in the skin of patients with hidradenitis suppurativa.
Researchers performed a pilot study to calculate EAA in the skin of patients with hidradenitis suppurativa.
Researchers performed a pilot...
11/09/2022
The Dermatologist

Q&As

Q&As
Dr Amit Garg: Comorbidity Screening in HS
05/19/2021
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights...
05/19/2021
The Dermatologist
Q&As
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
04/24/2021
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD...
04/24/2021
The Dermatologist
Q&As
The Who and When of Intralesional Injections for HS Treatment
03/26/2021
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met...
03/26/2021
The Dermatologist
Part 3
Q&As
Rebuilding Confidence in Alopecia Areata: Multidisciplinary, Holistic Support for Patients and Families
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Experts explore holistic and emotional support strategies to empower patients with alopecia areata—beyond medicine, toward identity and healing.
Experts explore holistic and emotional support strategies to empower patients with alopecia areata—beyond medicine, toward identity and healing.
Experts explore holistic and...
11/03/2025
The Dermatologist
part 2
Q&As
Part 2: Advancing the Treatment Landscape in Severe Alopecia Areata
09/01/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In Part 2 of this expert interview series, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna explore the latest treatment strategies for severe alopecia areata, including when to start JAK inhibitors, how to manage safety concerns,...
In Part 2 of this expert interview series, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna explore the latest treatment strategies for severe alopecia areata, including when to start JAK inhibitors, how to manage safety concerns,...
In Part 2 of this expert...
09/01/2025
The Dermatologist
Part 1 roundtable
Q&As
Part 1: Understanding the Emotional and Physical Toll of Alopecia Areata
08/04/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful...
08/04/2025
The Dermatologist
Brandon Adler, MD
Q&As
Insights Into Photoprotection Updates
02/08/2024
Jessica Garlewicz
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the...
02/08/2024
The Dermatologist
Glynis Ablon
Q&As
Enhancing Appearance Procedures
02/04/2024
Riya Gandhi, MA
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon...
02/04/2024
The Dermatologist
Jonathan Silverberg, MD, PhD, MPH
Q&As
Revolutionizing Atopic Dermatitis: Virtual Sessions on Optimizing Patient Care
12/13/2023
Jessica Garlewicz
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed...
12/13/2023
The Dermatologist
Elliott Campbell
Q&As
Gender Disparities and Advances in Cutaneous Melanoma
11/01/2023
Elliott Campbell, MD, FAAD
In this interview, Dr Elliott Campbell explores the increasing melanoma incidence among middle-aged women alongside stable rates in middle-aged men.
In this interview, Dr Elliott Campbell explores the increasing melanoma incidence among middle-aged women alongside stable rates in middle-aged men.
In this interview, Dr Elliott...
11/01/2023
The Dermatologist
Ilka A. Netravali, MD, PhD, FAAD
Q&As
Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis
10/30/2023
Ilka Arun Netravali, MD, PhD, FAAD
Dr Ilka Netravali shared insights from her study, “Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis.”
Dr Ilka Netravali shared insights from her study, “Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis.”
Dr Ilka Netravali shared...
10/30/2023
The Dermatologist
Jeremy Etzkorn-2019
Q&As
Nasal Function and Appearance Post Flap Repair: NAFEQ Study
09/26/2023
Jeremy Etzkorn, MD; Nicholas J. Golda, MD
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn...
09/26/2023
The Dermatologist
Steven Feldman
Q&As
Advancing Psoriasis Patient Care
09/25/2023
Steven R. Feldman, MD, PhD
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The...
09/25/2023
The Dermatologist

Multimedia

Dr Sherry Yang
Videos
Inflammation's Role in the Disease Progression of HS
11/17/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses the various causes of inflammation and their role in the disease progression of patients with HS.
Dr Sherry Yang discusses the various causes of inflammation and their role in the disease progression of patients with HS.
Dr Sherry Yang discusses the...
11/17/2021
The Dermatologist
Dr Sherry Yang
Videos
Demographics & Characteristics Associated With HS Diagnoses
11/12/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses patient demographics and characteristics that are associated with HS diagnoses.
Dr Sherry Yang discusses patient demographics and characteristics that are associated with HS diagnoses.
Dr Sherry Yang discusses patient...
11/12/2021
The Dermatologist
Dr Sherry Yang
Videos
How to Approach HS Treatment
11/05/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses how individualizing treatment plans for each patient is one of the best approaches to combatting HS symptoms.
Dr Sherry Yang discusses how individualizing treatment plans for each patient is one of the best approaches to combatting HS symptoms.
Dr Sherry Yang discusses how...
11/05/2021
The Dermatologist
Videos
Clinical Implications of HS and Hepatitis B/C
06/10/2021
Dr Cohen shares the clinical implications of hepatitis B and hepatitis C in patients with HS in this 8-minute video.
Dr Cohen shares the clinical implications of hepatitis B and hepatitis C in patients with HS in this 8-minute video.
Dr Cohen shares the clinical...
06/10/2021
The Dermatologist
Videos
Genetic Components and Hepatitis Risks in HS
06/10/2021
In this video interview, Dr Cohen highlights results of his recent study into HS and hepatitis B and C.
In this video interview, Dr Cohen highlights results of his recent study into HS and hepatitis B and C.
In this video interview, Dr...
06/10/2021
The Dermatologist
Podcasts
Updates in HS: Dr Rosenblum on Pathophysiology
12/15/2020
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Michael...
12/15/2020
The Dermatologist
Podcasts
Dr Iltefat Hamzavi on Managing Hidradenitis Suppurativa
09/16/2020
In this podcast, Iltefat Hamzavi, MD, discusses therapeutic options for managing flares, the role of lasers, and new therapies in the pipeline for hidradenitis suppurativa.
In this podcast, Iltefat Hamzavi, MD, discusses therapeutic options for managing flares, the role of lasers, and new therapies in the pipeline for hidradenitis suppurativa.
In this podcast, Iltefat...
09/16/2020
The Dermatologist
Melissa Piliang
Videos
Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
02/01/2026
Melissa Piliang, MD
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients seeking eyebrow...
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients seeking eyebrow...
In an insightful conversation...
02/01/2026
The Dermatologist
Peter Lio
Clinical Insights
Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis
01/20/2026
Peter Lio, MD, FAAD
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how...
01/20/2026
Allergy & Immunology
Stephen D. Hess, MD, PhD
Videos
Electrical Impedance Spectroscopy For Skin Cancer Screening
01/13/2026
Stephen D. Hess, MD, PhD
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he...
01/13/2026
The Dermatologist
melissa Piliang
Videos
JAK Inhibitors & Boxed Warnings
12/17/2025
Melissa Piliang, MD
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the...
12/17/2025
The Dermatologist
Part 3
Videos
Part 3: Rebuilding Confidence: Multidisciplinary and Holistic Approaches to Severe Alopecia Areata
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this...
11/03/2025
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
part 2
Videos
Part 2: From Topicals to Biologics: Evolution of Treatment Options in Severe Alopecia Areata
09/08/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna.
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna.
Explore how the treatment of...
09/08/2025
The Dermatologist
Dr Omid Hamid
Videos
Derm Advances: Insights From Dr Hamid on the Phase 3 C-POST Trial Results
08/15/2025
Omid Hamid, MD
08/15/2025
The Dermatologist
Glynis Ablon, MD, and Neil Sadick, MD presenters
Videos
Expert Perspectives: Hair Loss Management in Dermatology Practice
08/08/2025
Neil S. Sadick, MD, FAAD; Glynis Ablon
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the...
08/08/2025
The Dermatologist
George Murakawa
Videos
Infusion Therapy for Non-Melanoma Skin Cancer: A Dermatologist’s Guide
07/31/2025
George J. Murakawa, MD, PhD
Learn how one dermatology practice integrates in-office infusion therapy into daily clinical workflows, as this video explores the practical aspects of treating advanced non-melanoma skin cancers with systemic therapy, including a firsthand...
Learn how one dermatology practice integrates in-office infusion therapy into daily clinical workflows, as this video explores the practical aspects of treating advanced non-melanoma skin cancers with systemic therapy, including a firsthand...
Learn how one dermatology...
07/31/2025
The Dermatologist

Quizzes

severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Jessica Garlewicz
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist
hidradenitis suppurativa under arm
Quiz
Trivia: Internalized Skin Bias in HS
05/17/2022
Jessica Garlewicz
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options...
05/17/2022
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: How are Patients With HS and Hepatitis B or C Systemically Treated?
12/21/2021
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: What is the Optimal Dose Regimen Recommended for HS Lesions?
12/21/2021
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of...
12/21/2021
The Dermatologist
hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa and the Risk for Hepatitis B and C
12/20/2021
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with...
12/20/2021
The Dermatologist
hidradenitis in armpit
Quiz
Trivia: Characteristics Tied to New Hidradenitis Suppurativa Diagnoses
12/17/2021
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD,...
12/17/2021
The Dermatologist
hidradenitis
Quiz
Trivia: Risk for Therapy Discontinuation Among Patients With HS
12/10/2021
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of...
12/10/2021
The Dermatologist
hidradenitis tunneling
Quiz
Trivia: Ranking of Monotherapies for Hidradenitis Suppurativa
12/03/2021
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the...
12/03/2021
The Dermatologist
Hidradenitis Suppurativa, as shown here, is a terrible condition that can affect pediatric patients and their HS treatment.
Quiz
Trivia: Physical and Psychosocial Comorbidities in Pediatric HS
09/28/2021
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these...
09/28/2021
The Dermatologist
Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Quiz
Why Higher JAK Doses Raise Safety Concerns in AD
01/01/2026
Riya Gandhi, MA
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can...
01/01/2026
The Dermatologist
Quiz
What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?
01/01/2026
Riya Gandhi, MA
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
psoriasis
Quiz
Quiz: Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
Etiological Communication, Atopy, and First-Visit Navigation in AA
12/10/2025
Riya Gandhi, MA
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit...
12/10/2025
The Dermatologist
Quiz
Clinical Benefit of Accurate Risk Stratification in cSCC Management
12/04/2025
Jessica Garlewicz
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical...
12/04/2025
The Dermatologist
Quiz
Investigative Urgency and Autoimmune Framing in AA
12/01/2025
Riya Gandhi, MA
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive...
12/01/2025
The Dermatologist

News

Face
FDA Alerts
Bimekizumab FDA Approved for Moderate to Severe Hidradenitis Suppurativa
11/20/2024
Riya Gandhi, MA
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug...
11/20/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
FDA Alerts
Secukinumab Approved as New Biologic Treatment Option for Hidradenitis Suppurativa
11/01/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist
News
Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa
07/18/2023
Jessica Garlewicz
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a...
07/18/2023
The Dermatologist
News
Smoking and Obesity Are Important Research Questions for Managing Hidradenitis Suppurativa
04/10/2023
Lisa Kuhns, PhD, MD
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority...
04/10/2023
The Dermatologist
News
Complete Remission of Hidradenitis Suppurativa Reported After Treatment With Thoracodorsal Artery Perforator Flap
04/05/2023
Lisa Kuhns, PhD, MD
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator...
04/05/2023
The Dermatologist
News
Effectiveness and Pain Reduction Identified as the Most Important Treatment Attributes in Hidradenitis Suppurativa Management
01/31/2023
Lisa Kuhns, PhD, MD
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete...
01/31/2023
The Dermatologist
News
Hidradenitis Suppurativa Contributes to Relationship Disturbances
12/08/2022
Lisa Kuhns, PhD, MD
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine...
12/08/2022
The Dermatologist
News
Pediatric Hidradenitis Suppurativa Presents Similar Clinical Spectrum to Adult-Onset Disease
11/30/2022
Lisa Kuhns, PhD, MD
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
Stigmatization Has a Debilitating Impact on Patients With Hidradenitis Suppurativa
11/18/2022
Lisa Kuhns, PhD, MD
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an...
11/18/2022
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist

Popular Articles

Case Report
Successful Treatment of Recalcitrant Hailey-Hailey Disease
02/06/2024
Jarad Levin, MD; Katelin Harrell, MD; Kelsey Johnson, MS
In this article, we present a patient with a history of recalcitrant HHD who had clearance of her current disease flare with the topical JAK inhibitor ruxolitinib.
In this article, we present a patient with a history of recalcitrant HHD who had clearance of her current disease flare with the topical JAK inhibitor ruxolitinib.
In this article, we present a...
02/06/2024
The Dermatologist
Videos
Clinical Approach to the Diagnosis & Management of aCSCC and aBCC
03/14/2024
In this roundtable session, expert dermatologists describe current diagnostic approaches and risk factors for disease progression in advanced cutaneous squamous cell carcinoma (aCSCC) and advanced basal cell carcinoma (aBCC). This discussion...
In this roundtable session, expert dermatologists describe current diagnostic approaches and risk factors for disease progression in advanced cutaneous squamous cell carcinoma (aCSCC) and advanced basal cell carcinoma (aBCC). This discussion...
In this roundtable session,...
03/14/2024
The Dermatologist
NRS Approved Features
Optimizing Skin Care in Rosacea Management
05/03/2024
Riya Gandhi, MA
For this year’s National Rosacea Awareness Month, Dr Hilary Baldwin sheds light on the crucial role of proper skin care in managing rosacea alongside medical therapies.
For this year’s National Rosacea Awareness Month, Dr Hilary Baldwin sheds light on the crucial role of proper skin care in managing rosacea alongside medical therapies.
For this year’s National Rosacea...
05/03/2024
The Dermatologist
Cover Story
Sea Changes in Dermatology Residency Application Processes
06/06/2024
Aamir N. Hussain, MD, MAPP
What do students and mentors need to know to stay above water? This article spotlights the ongoing debates regarding dermatology residency applications and suggests a path forward for students and their mentors.
What do students and mentors need to know to stay above water? This article spotlights the ongoing debates regarding dermatology residency applications and suggests a path forward for students and their mentors.
What do students and mentors...
06/06/2024
The Dermatologist
cream
News
Local Tolerability of Topical Roflumilast Across Dermatologic Conditions in Phase 3 Trials
06/25/2024
Riya Gandhi, MA
Topical roflumilast has demonstrated robust local tolerability profiles in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
Topical roflumilast has demonstrated robust local tolerability profiles in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
Topical roflumilast has...
06/25/2024
The Dermatologist
jan/feb issue

Current Issue

January 2026
Volume 34
Issue 1
Current Issue
Issue Archive

Latest Quizzes and Trivia

severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Jessica Garlewicz
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist
hidradenitis suppurativa under arm
Quiz
Trivia: Internalized Skin Bias in HS
05/17/2022
Jessica Garlewicz
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options...
05/17/2022
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: How are Patients With HS and Hepatitis B or C Systemically Treated?
12/21/2021
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: What is the Optimal Dose Regimen Recommended for HS Lesions?
12/21/2021
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of...
12/21/2021
The Dermatologist
hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa and the Risk for Hepatitis B and C
12/20/2021
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with...
12/20/2021
The Dermatologist
hidradenitis in armpit
Quiz
Trivia: Characteristics Tied to New Hidradenitis Suppurativa Diagnoses
12/17/2021
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD,...
12/17/2021
The Dermatologist
hidradenitis
Quiz
Trivia: Risk for Therapy Discontinuation Among Patients With HS
12/10/2021
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of...
12/10/2021
The Dermatologist
hidradenitis tunneling
Quiz
Trivia: Ranking of Monotherapies for Hidradenitis Suppurativa
12/03/2021
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the...
12/03/2021
The Dermatologist
Hidradenitis Suppurativa, as shown here, is a terrible condition that can affect pediatric patients and their HS treatment.
Quiz
Trivia: Physical and Psychosocial Comorbidities in Pediatric HS
09/28/2021
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these...
09/28/2021
The Dermatologist
Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Quiz
Why Higher JAK Doses Raise Safety Concerns in AD
01/01/2026
Riya Gandhi, MA
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can...
01/01/2026
The Dermatologist
Quiz
What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?
01/01/2026
Riya Gandhi, MA
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
psoriasis
Quiz
Quiz: Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
Etiological Communication, Atopy, and First-Visit Navigation in AA
12/10/2025
Riya Gandhi, MA
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit...
12/10/2025
The Dermatologist
Quiz
Clinical Benefit of Accurate Risk Stratification in cSCC Management
12/04/2025
Jessica Garlewicz
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical...
12/04/2025
The Dermatologist
Quiz
Investigative Urgency and Autoimmune Framing in AA
12/01/2025
Riya Gandhi, MA
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive...
12/01/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use